Efficacy of Topical Cholesterol and Statin Combination Therapy in the Treatment of Porokeratosis: A Systematic Review and Meta-Analysis
CONCLUSION: This underpowered meta-analysis provides limited, preliminary evidence supporting the efficacy of topical cholesterol/statin therapy. Overall, quality studies and aggregated sample size are limited; future large clinical trials are needed to further elucidate the role of topical cholesterol/statin therapy in the treatment of porokeratosis. J Drugs Dermatol. 2023;22(12):1160-1165. doi:10.36849/JDD.7775.PMID:38051843 | DOI:10.36849/JDD.7775
Source: Journal of Drugs in Dermatology - Category: Dermatology Authors: Fiore Casale Nathan Walters Aaron Peach Joanna Dong Source Type: research
More News: Atorvastatin Calcium | Cancer & Oncology | Carcinoma | Cholesterol | Clinical Trials | Crestor | Dermatitis | Dermatology | Fluvastatin | Genetics | Lipitor | Lovastatin | Peaches | Pravastatin | Rosuvastatin | Simvastatin | Skin | Skin Cancer | Squamous Cell Carcinoma | Statin Therapy | Study | Zivast | Zocor